Author

Shun‐Fa Yang

Chung Shan Medical University HospitalORCID 0000-0002-0365-7927Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:GWAS / association mapping· 2 Assay:GWAS summary statistics· 2 Approach:statistical model· 2 Research Focus:variant effect prediction· 2 Approach:benchmark study· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1

Frequent Co-Authors

Cathy S.-J. FanniD· 3 shared Chih‐Hung LaiiD· 3 shared Ching‐Heng LiniD· 3 shared Erh‐Chan YehiD· 3 shared Hsin TungiD· 3 shared Hsin-Chien YeniD· 3 shared Hsin‐Chou YangiD· 3 shared Hung‐Hsin CheniD· 3 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Cathy S.-J. FannORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GeneticsNaturePeer-reviewedOct 15, 2025

The Taiwan Precision Medicine Initiative: A Cohort for Large-Scale Studies

Hsin‐Chou Yang, Pui–Yan Kwok, Ling-Hui Li…·Ming‐Chin Yu

The Taiwan Precision Medicine Initiative (TPMI) recruits a large cohort for genetic and electronic medical record studies to advance precision medicine.

47 citationstop 1%

humanGWAS summary statistics

𝕏 PostBluesky

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedJul 9, 2025

Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort

Chun-Yu Wei, Ming‐Shien Wen, Chih-Kuang Cheng…·Chien‐Ming Lin

The paper evaluates the clinical impact of pharmacogenetic risk variants in a large Han Chinese cohort, finding that while most carry risk variants, the excess risk of adverse events is small and most patients do not experience adverse outcomes.

15 citationstop 1%

humanGWAS summary statistics

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintOct 21, 2024

Deleterious Variants Contribute Minimal Excess Risk in Large-Scale Testing

Yen‐Tsung Huang, En‐Yu Lai, Jia-Ying Su…·Chang‐Hsun Hsieh

The paper analyzes 292 disease-relevant deleterious variants in 486,956 participants to assess their risk differences, finding most have minimal impact.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky